Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
07/2008
07/23/2008CN101225107A Polypeptide organic compound and use thereof in hetero transplantation
07/23/2008CN101225106A Short peptide suppressing growth of cancer cell and uses thereof
07/22/2008US7402663 Obesity, antidiabetic agents
07/22/2008US7402653 Biologically active peptides
07/22/2008US7402563 EPF derived peptides and therapeutic compositions
07/22/2008US7402560 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells
07/22/2008US7402556 Prodrugs activated by plasmin and their use in cancer chemotherapy
07/22/2008US7402401 Determining whether ST receptor protein or mRNA encoding it is present in lymph node; polymerase chain reaction and binding assay
07/22/2008US7402315 Peptide of given sequence; fused to glutathione-S-transferase; use in immunoassays and vaccines
07/22/2008CA2163805C Novel activating factor of leukocytes
07/22/2008CA2017025C Tumor necrosis factor binding protein ii, its purification and antibodies thereto
07/17/2008WO2008086161A1 Macrocyclic hepatitis c protease inhibitors
07/17/2008WO2008085888A1 G protein-coupled receptor and modulators thereof for the treatment of gaba-related neurological disorders including sleep-related disorders
07/17/2008WO2008085191A1 Polypeptide inhibitors of hsp27 kinase and uses therefor
07/17/2008WO2008084899A1 The enterocyte-transcytotic, tissue target and m cell target peptide identified by the phage display process and drug delivery systems using the same
07/17/2008WO2008084652A1 Vascular endothelial cell-binding peptide
07/17/2008WO2008084483A1 Novel therapeutics based on tau/microtubule dynamics
07/17/2008WO2008083729A1 Radiolabelling via fluorination of aziridines
07/17/2008WO2008083678A2 Pharmaceutically active compounds
07/17/2008WO2008083543A1 Nitrogen-containing heterocyclic modified compounds and uses thereof
07/17/2008WO2008083493A1 Stabilization of cyclic peptide structures
07/17/2008WO2008024195A3 Methods and compositions for conserving and/or preparing an organ or tissue for transplant
07/17/2008US20080171853 Formed via solid-state chemistry with 4-methylbenzylhydrylamine functionalized crosslinked polystyrene resin; deblocking, deprotecting; methylation
07/17/2008US20080171852 Peptide linker comprising thrombin cleavage site; enhancing recovery and purification of exogenously expressed polypeptides
07/17/2008US20080171850 Isomeric mixture of a cyclosporine analogue modified at the 1-amino acid residue with a 1,3-diene substituent; antiinflammatory agents; autoimmune disease; side effect reduction; reduced toxicity
07/17/2008US20080171699 [(N,N- epsilon -Dimethyl)-D-lysyl]8cyclosporine; hepatitis C viricide
07/17/2008US20080171693 Such as Survivn; antiproliferative, antitumor agents; apoptosis; a polypeptide peptidomimetic that includes the amino acid sequence His-Ser-Ser-Gly-Cys
07/17/2008US20080171348 GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity
07/17/2008US20080171339 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
07/17/2008US20080171060 Lymphocyte receptor peptide for use in prevention and treatment of viral infection, cell proliferative, cardiovascular and allergic disorders; enhancing cytokine production
07/17/2008US20080171035 Mammalian cell membrane proteins; related reagents
07/17/2008US20080170991 Selectively targeted antimicrobial peptides and the use thereof
07/17/2008DE102007002386A1 Pharmazeutisch wirksame Verbindungen Pharmaceutically active compounds
07/17/2008CA2689296A1 Polypeptide inhibitors of hsp27 kinase and uses therefor
07/17/2008CA2679563A1 Macrocyclic hepatitis c protease inhibitors
07/17/2008CA2675029A1 Pharmaceutically active compounds
07/17/2008CA2675024A1 Stabilization of cyclic peptide structures
07/17/2008CA2674408A1 Radiolabelling via fluorination of aziridines
07/17/2008CA2674378A1 Methods and compositions related to clot binding compounds
07/16/2008EP1944610A1 Engineering affinity ligands for macromolecules
07/16/2008EP1944312A1 Peptides that specifically bind HGF receptor (CMET) and uses thereof
07/16/2008EP1944288A1 Radiolabelling via fluorination of aziridines
07/16/2008EP1943342A1 Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
07/16/2008EP1943268A1 Use of the gonadotropin-releasing hormone ii antagonists and its analogues
07/16/2008EP1942923A1 Agonist peptides of basic fibroblast growth factor (bfgf) and the method of reduction of wrinkle on skin, darkening of hair and acceleration of wound healing
07/16/2008EP1814901B1 Citrulline peptides derived from fibrin and recognised by rheumatoid arthritis specific autoantibodies and the use thereof
07/16/2008EP1786380A4 Peptide-based body surface reagents for personal care
07/16/2008EP1401490B1 Tsg101 as inhibitor of hiv production
07/16/2008EP1313440B1 Dental products comprising bone growth enhancing peptide
07/16/2008CN101223187A New peptides useful as dual caspase-2/-6 inhibitors and their biological applications
07/16/2008CN101222942A Peptides for use in the treatment of obesity
07/16/2008CN101220089A Chinese South China sea signal conus neurotoxin gene Lt3.1 and uses thereof
07/16/2008CN101220084A Polyglycol modifying ferric iron deuterohemin short peptide compound and production method thereof
07/16/2008CN101220083A Synthetic polypeptide and uses thereof
07/16/2008CN100402549C Bridged bicyclic serine protease inhibitors
07/16/2008CN100402092C Gas bearing activator of dry powder in use for diagnosing and/or treating thrombus
07/15/2008US7399827 For diagnosis and for vaccine based therapy of neoplasms of prostate, testis and uterus; inhibiting the growth of malignant cells expressing PAGE-4, and methods of inducing an enhanced immune response to PAGE-4-expressing cancers
07/15/2008US7399826 Promoting union of bone tissue in fracture, promoting bone growth in spinal fusion, or promoting bone growth in therapy for osteoporosis; 13-amino acid polypeptide
07/15/2008US7399823 Antimicrobial theta defensins and methods of using same
07/15/2008US7399749 For therapy and prophylaxis of disorders associated with the HCV protease
07/15/2008US7399644 Determining concentration of target antibodies in mixtures; food analysis; disease diagnosis
07/15/2008US7399630 Cell culture vessel having a polymer surface, a cell adhesion resistant material (CAR) bonded to the polymer (e.g., hyaluronic acid), and one or more peptides covalently bound to the CAR material that promote adherence of cells that do not adhere to the CAR layer in the absence of the peptides
07/15/2008CA2274149C Peptides and compounds that bind to a receptor
07/15/2008CA2250861C Cyclic adhesion inhibitors
07/15/2008CA2250630C Novel lantibiotic related to actagardine, and processes for the preparation and use thereof
07/15/2008CA2142370C T cell epitopes of ryegrass pollen allergen
07/10/2008WO2008081581A1 Foxp3 peptide vaccine
07/10/2008WO2008080845A1 Methods for the synthesis of cyclic peptides
07/10/2008WO2007090194A3 Lymphatic zip codes in tumors and pre-malignant lesions
07/10/2008WO2007070372A3 Compositions and methods for inhibiting cellular proliferation
07/10/2008WO2002072778A3 Method for identifying inhibitors of g protein coupled receptor signaling
07/10/2008US20080167251 Angiotensin-(1-7) and Angiotensin-(1-7) Agonists for Inhibition of Cancer Cell Growth
07/10/2008US20080167247 modulator of PKC V5 isozyme-specific peptide, or a modification, derivation, fragment, combination, or hybrid thereof; treatment of pain, cancer
07/10/2008US20080167199 Multimerization of HIV-1 vif protein as a therapeutic target
07/10/2008US20080166739 GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity
07/10/2008US20080166388 Which cause little lysis of human red blood cells at concentrations that kill Candida albicans; kits; stent, valve, pacemaker, defibrillator, artificial joint, prosthesis, neurostimulator, ventricular assist device, congestive heart failure device, indwelling catheter, insulin pump, incontinence device
07/10/2008US20080166352 B7 related protein-1specific immunogobulin for use in treatment and prevention of asthma, skin, rheumatic and autoimmune disorders
07/10/2008US20080166293 Receptor-mediated uptake of peptides that bind the human transferrin receptor
07/10/2008CA2711003A1 Targeting of ews-fli1 as anti-tumor therapy
07/10/2008CA2674365A1 Foxp3 peptide vaccine
07/10/2008CA2673229A1 Methods for the synthesis of cyclic peptides
07/09/2008EP1940873A2 Novel fgf receptor binding compounds comprising peptide fragments of neural cell adhesion molecule l1
07/09/2008EP1940866A1 Peptides for promoting hair growth and improving wrinkle and cosmetic compositions comprising the same
07/09/2008EP1940865A2 Novel protein transduction domains and uses therefor
07/09/2008EP1404362B1 Signal-1/signal-2 bifunctional peptide inhibitors
07/09/2008EP0970121B1 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis
07/09/2008CN101217970A Compositions, methods and uses for a novel family of peptides
07/09/2008CN101215601A Effectors of innate immunity determination
07/09/2008CN101215324A Exenatide short peptide simulation peptide and application thereof in preparing medicament for curing diabetes
07/09/2008CN101215323A Human AD7C-NTP antigen determinant polypeptide, antibody and application thereof in diagnosis kit
07/09/2008CN101214380A Method and carrier complexes for delivering molecules to cells
07/08/2008US7396925 Volatilizable solid phase supports for compound synthesis
07/08/2008US7396904 Tumor-associated peptides binding to MHC-molecules
07/08/2008US7396817 Reducing symptoms of viral disease, especially hepatitis B, and stimulating the immune system
07/08/2008US7396814 Metallopeptide compositions for treatment of sexual dysfunction
07/08/2008US7396661 Expressing Fab/immunoglobulin fragments in bacterial cells; diagnosis and treatment of diabetes, multiple sclerosis and rheumatoid arthritis
07/08/2008CA2372377C A novel inhibitor of beta amyloid cleavage enzyme
07/08/2008CA2250712C Chimeric isoprenoid synthases and uses thereof
07/03/2008WO2008077993A1 Novel peptides
07/03/2008WO2008077938A1 Modulators of talin/integrin association and use thereof